Monitoring oncogenic B-RAF-induced senescence in melanocytes

Methods Mol Biol. 2013:965:313-26. doi: 10.1007/978-1-62703-239-1_21.

Abstract

The B-RAF kinase is a downstream effector of the RAS family of proto-oncogenes and is constitutively activated in the majority of human melanomas. The common oncogenic B-RAF(V600E) mutant cooperates with additional genetic lesions to transform immortal murine and human cells. In primary cells, however, B-RAF(V600E) triggers a rapid cell cycle arrest that is phenotypically indistinguishable from cellular senescence. Here we describe the analyses of B-RAF-induced senescence in primary human melanocytes using recombinant lentiviruses.

MeSH terms

  • Bromodeoxyuridine / metabolism
  • Cell Culture Techniques
  • Cell Line, Tumor
  • Cellular Senescence / genetics*
  • Genetic Engineering / methods*
  • Humans
  • Lentivirus / genetics
  • Melanocytes / cytology*
  • Melanocytes / metabolism
  • Microscopy, Fluorescence
  • Mutation
  • Oncogenes / genetics*
  • Proto-Oncogene Proteins B-raf / genetics*
  • Skin / cytology
  • Staining and Labeling
  • Transduction, Genetic
  • Transgenes / genetics
  • beta-Galactosidase / metabolism

Substances

  • Proto-Oncogene Proteins B-raf
  • beta-Galactosidase
  • Bromodeoxyuridine